| 1 | Primary Care Clinicians’ Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment | 2.6 | 1 | Citations (PDF) |
| 2 | Antithrombotic Therapy for VTE DiseaseChest, 2024, 166, 388-404 | 0.5 | 80 | Citations (PDF) |
| 3 | Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolism | 0.6 | 0 | Citations (PDF) |
| 4 | Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial | 5.3 | 132 | Citations (PDF) |
| 5 | Comparative Frequency of Venous Thromboembolism in Patients Admitted to the Hospital with SARS-CoV-2 Infection versus Community-acquired Pneumonia | 3.7 | 4 | Citations (PDF) |
| 6 | Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort | 2.0 | 1 | Citations (PDF) |
| 7 | Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease | 3.7 | 43 | Citations (PDF) |
| 8 | Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment | 0.6 | 2 | Citations (PDF) |
| 9 | A systematic review of biomarkers among hospitalized patients with
<scp>COVID</scp>
‐19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables
<scp>Scientific and Standardization Committee</scp>
of the
<scp>ISTH</scp> | 0.6 | 3 | Citations (PDF) |
| 10 | D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent Validation | 1.8 | 5 | Citations (PDF) |
| 11 | Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [<scp>CAF</scp>] trial) | 1.4 | 21 | Citations (PDF) |
| 12 | Natural Language Processing Performance for the Identification of Venous Thromboembolism in an Integrated Healthcare System | 1.8 | 25 | Citations (PDF) |
| 13 | Trauma patients at risk for venous thromboembolism who undergo routine duplex ultrasound screening experience fewer pulmonary emboli: A prospective randomized trial | 2.6 | 26 | Citations (PDF) |
| 14 | Cost-effectiveness of managing low-risk pulmonary embolism patients without hospitalization. The low-risk pulmonary embolism prospective management study | 1.5 | 7 | Citations (PDF) |
| 15 | Post‐discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers | 0.6 | 7 | Citations (PDF) |
| 16 | Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation | 1.6 | 6 | Citations (PDF) |
| 17 | Antithrombotic Therapy for VTE DiseaseChest, 2021, 160, e545-e608 | 0.5 | 805 | Citations (PDF) |
| 18 | Executive SummaryChest, 2021, 160, 2247-2259 | 0.5 | 348 | Citations (PDF) |
| 19 | Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance | 0.6 | 14 | Citations (PDF) |
| 20 | Timing of parenteral anticoagulation after thrombolysis for the treatment of pulmonary embolism | 2.3 | 2 | Citations (PDF) |
| 21 | Predicting postdischarge hospital‐associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkers | 0.6 | 3 | Citations (PDF) |
| 22 | 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment TrendsLupus, 2020, 29, 1571-1593 | 1.7 | 116 | Citations (PDF) |
| 23 | Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis | 3.7 | 120 | Citations (PDF) |
| 24 | Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta‐analysis | 3.7 | 9 | Citations (PDF) |
| 25 | Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment | 5.3 | 27 | Citations (PDF) |
| 26 | Choosing ultrasound technique for suspected deep vein thrombosis: which is best? | 1.6 | 1 | Citations (PDF) |
| 27 | Diagnostic yield of pulmonary embolism testing in patients presenting to the emergency department with syncope | 0.6 | 5 | Citations (PDF) |
| 28 | THROMBOEMBOLISM-RISK-BASED ALGORITHM DECREASES ANTICOAGULATION RATES AND BLEEDING RISK AFTER LIVER TRANSPLANTATION | 0.8 | 0 | Citations (PDF) |
| 29 | Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty | 7.3 | 12 | Citations (PDF) |
| 30 | Saving the brain from catheter ablation of atrial fibrillation: the role of pre- and peri-procedural anticoagulation | 2.2 | 2 | Citations (PDF) |
| 31 | Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM‐DVT): Methods of a prospective single‐arm management study | 0.6 | 18 | Citations (PDF) |
| 32 | Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study | 2.0 | 18 | Citations (PDF) |
| 33 | Management of Low-Risk Pulmonary Embolism Patients Without HospitalizationChest, 2018, 154, 249-256 | 0.5 | 72 | Citations (PDF) |
| 34 | Weight-based enoxaparin dosing and deep vein thrombosis in hospitalized trauma patients: A double-blind, randomized, pilot study | 1.9 | 16 | Citations (PDF) |
| 35 | Protocol Modification of Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome Study | 1.8 | 43 | Citations (PDF) |
| 36 | Preemptive Anticoagulation in Patients With a High Pretest Probability of Pulmonary EmbolismChest, 2018, 153, 1153-1159 | 0.5 | 8 | Citations (PDF) |
| 37 | Comparative thrombosis risk of vascular access devices among critically ill medical patients | 2.3 | 20 | Citations (PDF) |
| 38 | Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals | 0.6 | 16 | Citations (PDF) |
| 39 | Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism | 2.3 | 15 | Citations (PDF) |
| 40 | Atrial fibrillation incrementally increases dementia risk across all CHADS 2 and CHA 2 DS 2 VASc strata in patients receiving long-term warfarin | 2.9 | 43 | Citations (PDF) |
| 41 | The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation | 1.6 | 5 | Citations (PDF) |
| 42 | Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty | 7.3 | 220 | Citations (PDF) |
| 43 | 15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report 2017, , 317-338 | | 19 | Citations (PDF) |
| 44 | The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) initiative: A summary and review of peripherally inserted central catheter and venous catheter appropriate use | 1.4 | 39 | Citations (PDF) |
| 45 | Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation | 1.6 | 145 | Citations (PDF) |
| 46 | Follow-up of Incidental Pulmonary Nodules and the Radiology Report | 2.4 | 30 | Citations (PDF) |
| 47 | Electronic Alerts, Comparative Practitioner Metrics, and Education Improves Thromboprophylaxis and Reduces Thrombosis | 1.9 | 18 | Citations (PDF) |
| 48 | Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications | 4.3 | 47 | Citations (PDF) |
| 49 | Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome | 1.8 | 91 | Citations (PDF) |
| 50 | Guidance for the evaluation and treatment of hereditary and acquired thrombophilia | 1.9 | 288 | Citations (PDF) |
| 51 | Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation | 2.0 | 1 | Citations (PDF) |
| 52 | Antithrombotic Therapy for VTE DiseaseChest, 2016, 149, 315-352 | 0.5 | 4,489 | Citations (PDF) |
| 53 | Venous Thromboembolism in Critically Ill Medical Patients Receiving Chemoprophylaxis | 1.8 | 19 | Citations (PDF) |
| 54 | Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study | 1.5 | 3 | Citations (PDF) |
| 55 | Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long‐Term Risk of Dementia | 2.2 | 43 | Citations (PDF) |
| 56 | Ultrasound of the Whole Arm to Manage Suspected Upper-Extremity Deep Venous Thrombosis | 6.1 | 0 | Citations (PDF) |
| 57 | The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities | 1.9 | 83 | Citations (PDF) |
| 58 | Computerized Clinical Decision Support Improves Warfarin Management and Decreases Recurrent Venous Thromboembolism | 1.8 | 14 | Citations (PDF) |
| 59 | Follow-up of Incidental Pulmonary Nodules and the Radiology Report | 2.4 | 98 | Citations (PDF) |
| 60 | Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia | 0.7 | 144 | Citations (PDF) |
| 61 | Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation | 1.8 | 29 | Citations (PDF) |
| 62 | Assessment of the Safety and Efficiency of Using an Age-Adjusted D-dimer Threshold to Exclude Suspected Pulmonary EmbolismChest, 2014, 146, 1444-1451 | 0.5 | 34 | Citations (PDF) |
| 63 | Intermittent pneumatic compression in patients with stroke | 14.8 | 4 | Citations (PDF) |
| 64 | ANTITHROMBOTIC MANAGEMENT OF ACUTE CORONARY SYNDROME IN PATIENTS WITH ATRIAL FIBRILLATION IN THE INTERMOUNTAIN HEART COLLABORATIVE STUDY | 1.2 | 0 | Citations (PDF) |
| 65 | Adherence to PIOPED II Investigators' Recommendations for Computed Tomography Pulmonary Angiography | 1.9 | 72 | Citations (PDF) |
| 66 | Withholding Anticoagulation Following a Single Negative Whole-Leg Ultrasound in Patients at High Pretest Probability for Deep Vein Thrombosis | 1.8 | 8 | Citations (PDF) |
| 67 | Reduction of Peripherally Inserted Central Catheter-Associated DVTChest, 2013, 143, 627-633 | 0.5 | 94 | Citations (PDF) |
| 68 | A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II) | 10.1 | 219 | Citations (PDF) |
| 69 | Radiation and Chest CT Scan ExaminationsChest, 2012, 142, 750-760 | 0.5 | 119 | Citations (PDF) |
| 70 | The Reply | 1.9 | 1 | Citations (PDF) |
| 71 | Diagnosis and management of upper extremity deep-vein thrombosis in adults | 4.3 | 132 | Citations (PDF) |
| 72 | Derivation and Validation of a Simple Model to Identify Venous Thromboembolism Risk in Medical Patients | 1.9 | 120 | Citations (PDF) |
| 73 | Guideline-Based Utilization Of CT Pulmonary Angiography For Suspected Pulmonary Embolism 2011, , A2688-A2688 | | 0 | Citations (PDF) |
| 74 | Treatment of Chronic Lead Toxicity With Succimer | 0.7 | 7 | Citations (PDF) |
| 75 | Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound | 7.3 | 188 | Citations (PDF) |
| 76 | Risk of Symptomatic DVT Associated With Peripherally Inserted Central CathetersChest, 2010, 138, 803-810 | 0.5 | 240 | Citations (PDF) |
| 77 | Safety of Excluding Suspected Deep Vein Thrombosis with a Single Whole-Leg Compression Ultrasound: Systematic Review and Meta-Analysis.Blood, 2009, 114, 243-243 | 1.0 | 1 | Citations (PDF) |
| 78 | The use of a fixed high sensitivity to evaluate five D-dimer assays' ability to rule out deep venous thrombosis: a novel approach | 2.5 | 8 | Citations (PDF) |
| 79 | Hepatic epithelioid hemangioendothelioma presenting as liver infarction | 6.1 | 4 | Citations (PDF) |
